C-Reactive Protein Levels and Risk of Cardiovascular Diseases: A Two-Sample Bidirectional Mendelian Randomization Study

por Kuppa, Annapurna, Tripathi, Himi, Al-Darraji, Ahmed, Tarhuni, Wadea M., Abdel-Latif, Ahmed
Publicado 2023

Prognostic Significance of Activated Monocytes in Patients with ST-Elevation Myocardial Infarction

por Abo-Aly, Mohamed, Shokri, Elica, Chelvarajan, Lakshman, Tarhuni, Wadea M., Tripathi, Himi, Abdel-Latif, Ahmed
Publicado 2023

A mutation in the atrial-specific myosin light chain gene (MYL4) causes familial atrial fibrillation

por Orr, Nathan, Arnaout, Rima, Gula, Lorne J., Spears, Danna A., Leong-Sit, Peter, Li, Qiuju, Tarhuni, Wadea, Reischauer, Sven, Chauhan, Vijay S., Borkovich, Matthew, Uppal, Shaheen, Adler, Arnon, Coughlin, Shaun R., Stainier, Didier Y. R., Gollob, Michael H.
Publicado 2016

Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial

por Eikelboom, John W, Jolly, Sanjit S, Belley-Cote, Emilie P, Whitlock, Richard P, Rangarajan, Sumathy, Xu, Lizhen, Heenan, Laura, Bangdiwala, Shrikant I, Luz Diaz, Maria, Diaz, Rafael, Yusufali, Afzalhussein, Kumar Sharma, Sanjib, Tarhuni, Wadea M, Hassany, Mohamed, Avezum, Alvaro, Harper, William, Wasserman, Sean, Almas, Aysha, Drapkina, Oxana, Felix, Camilo, Lopes, Renato D, Berwanger, Otavio, Lopez-Jaramillo, Patricio, Anand, Sonia S, Bosch, Jackie, Choudhri, Shurjeel, Farkouh, Michael E, Loeb, Mark, Yusuf, Salim
Publicado 2022

Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial

por Eikelboom, John W, Jolly, Sanjit S, Belley-Cote, Emilie P, Whitlock, Richard P, Rangarajan, Sumathy, Xu, Lizhen, Heenan, Laura, Bangdiwala, Shrikant I, Tarhuni, Wadea M, Hassany, Mohamed, Kontsevaya, Anna, Harper, William, Sharma, Sanjib Kumar, Lopez-Jaramillo, Patricio, Dans, Antonio L, Palileo-Villanueva, Lia M, Avezum, Alvaro, Pais, Prem, Xavier, Denis, Felix, Camilo, Yusufali, Afzalhussein, Lopes, Renato D, Berwanger, Otavio, Ali, Zeeshan, Wasserman, Sean, Anand, Sonia S, Bosch, Jackie, Choudhri, Shurjeel, Farkouh, Michael E, Loeb, Mark, Yusuf, Salim
Publicado 2022

The Anti-Coronavirus Therapies (ACT) Trials: Design, Baseline Characteristics, and Challenges

por Eikelboom, John, Rangarajan, Sumathy, Jolly, Sanjit S., Belley-Cote, Emilie P., Whitlock, Richard, Beresh, Heather, Lewis, Gayle, Xu, Lizhen, Chan, Noel, Bangdiwala, Shrikant, Diaz, Rafael, Orlandini, Andres, Hassany, Mohamed, Tarhuni, Wadea M., Yusufali, A.M., Sharma, Sanjib Kumar, Kontsevaya, Anna, Lopez-Jaramillo, Patricio, Avezum, Alvaro, Dans, Antonio L., Wasserman, Sean, Felix, Camilo, Kazmi, Khawar, Pais, Prem, Xavier, Denis, Lopes, Renato D., Berwanger, Otavio, Nkeshimana, Menelas, Harper, William, Loeb, Mark, Choudhri, Shurjeel, Farkouh, Michael E., Bosch, Jackie, Anand, Sonia S., Yusuf, Salim
Publicado 2022